Clinical Trial Update: Nasal Inhalation of Tobramycin in Patients With Cystic Fibrosis and Pseudomonas Aeruginosa Colonization [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating nasal inhalation of tobramycin in patients with cystic fibrosis and Pseudomonas aeruginosa colonization; the study status is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis
• Pseudomonas Aeruginosa Colonization

Drugs mentioned

• TOBRAMYCIN (Tobramycin)

Snippet

Sponsor: University of Jena | Conditions: Cystic Fibrosis, Pseudomonas Aeruginosa | Phase 2 | Status: COMPLETED